Nexalin Technology (NXL) to Release Earnings on Friday

Nexalin Technology (NASDAQ:NXL) is projected to release its results before the market opens on Friday, March 13th. Analysts expect Nexalin Technology to post earnings of ($0.12) per share and revenue of $0.08 million for the quarter.

Nexalin Technology Price Performance

NASDAQ:NXL opened at $0.43 on Thursday. The company’s fifty day moving average price is $0.56 and its 200-day moving average price is $0.88. Nexalin Technology has a 1-year low of $0.37 and a 1-year high of $2.57. The firm has a market capitalization of $7.97 million, a P/E ratio of -0.65 and a beta of 4.05.

Institutional Trading of Nexalin Technology

Several large investors have recently bought and sold shares of the business. Susquehanna International Group LLP acquired a new position in shares of Nexalin Technology during the 3rd quarter valued at about $57,000. Renaissance Technologies LLC increased its position in Nexalin Technology by 119.2% during the fourth quarter. Renaissance Technologies LLC now owns 122,100 shares of the company’s stock worth $68,000 after purchasing an additional 66,400 shares during the last quarter. Geode Capital Management LLC raised its stake in Nexalin Technology by 23.4% during the fourth quarter. Geode Capital Management LLC now owns 150,274 shares of the company’s stock worth $84,000 after purchasing an additional 28,454 shares during the period. Finally, PEAK6 LLC acquired a new stake in shares of Nexalin Technology during the 4th quarter worth approximately $266,000. Hedge funds and other institutional investors own 0.65% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts recently commented on NXL shares. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Nexalin Technology in a report on Monday, December 29th. Wall Street Zen downgraded Nexalin Technology from a “hold” rating to a “sell” rating in a report on Saturday, November 22nd. One investment analyst has rated the stock with a Buy rating and one has given a Sell rating to the company. Based on data from MarketBeat, Nexalin Technology currently has an average rating of “Hold” and a consensus target price of $5.00.

About Nexalin Technology

Nexalin Technology, Inc is a U.S.-based medical device company specializing in noninvasive neuromodulation therapies for mental health conditions. The company develops and markets the Nexalin® medical device platform, which delivers proprietary alternating current waveforms to targeted areas of the brain through forehead-mounted electrodes. Its technology is designed to modulate neural activity without pharmaceuticals, positioning the company within the growing field of digital therapeutics and neurostimulation.

The Nexalin device has received U.S.